Analyst Ratings for Bolt Biotherapeutics, Inc. (BOLT)

BOLT Rating Summary

BOLT Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BOLT
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $27.50 (+589.2%) * Over Last 12-Mos
Rating Score: 3.8 / 10   Percentile Rank: 36%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/28/2026 Rodman & Renshaw Michael King Jr. New Coverage Buy
(N/A)
22.00
(N/A)
5.28
(3.99)
-24.43% Details
4/6/2026 Jones Trading Boris Peaker New Coverage Hold
(N/A)
N/A
(N/A)
4.29
(3.99)
-6.99% Details